Cervical Cancer News and Research

RSS

Cancer is a disease in which cells in the body grow out of control. Cancer is always named for the part of the body where it starts, even if it spreads to other body parts later. When cancer starts in the cervix, it is called cervical cancer. The cervix is the lower, narrow end of the uterus. Also known as the womb, the uterus is where a baby grows when a woman is pregnant. The cervix connects the upper part of the uterus to the vagina (birth canal).

Cervical cancer is highly preventable in most Western countries because screening tests and a vaccine to prevent HPV infections are available. When cervical cancer is found early, it is highly treatable and associated with long survival and good quality of life.

PBCC supports passage of health care legislation

The PA Breast Cancer Coalition is encouraged by the United States House of Representatives' passing of a health care reform bill, to be signed into law by President Obama this week.

24 Mar 2010

HPV test could help predict risk of cervical cancer, but more research needed

Testing for the human papillomavirus (HPV) - the major cause of cervical cancer - may not help to identify women who are at risk of the disease, a new UK study suggests.

24 Mar 2010

Cancer Research UK's special Race for Life event takes place in Essex

CANCER Research UK today (Monday) launched a special Race for Life event in memory of Jade Goody, to take place in the reality star's adopted home county of Essex, on Sunday 6th June. A year on from her death, Jade's bridesmaids are calling on women to enter the commemorative event.

23 Mar 2010

Global breast cancer organization recognizes Northeast Ohio Affiliate of Susan G. Komen for the Cure

The Northeast Ohio Affiliate of Susan G. Komen for the Cure was honored Saturday night as the “Affiliate of the Year” by the global breast cancer organization. The award was presented in front of hundreds of staff, board members and volunteers from the 122 affiliates nationwide at Komen’s Annual Affiliate Leadership Conference in Dallas, Texas.

22 Mar 2010

GSK's 2009 Corporate Responsibility Report published online

In its 2009 Corporate Responsibility Report published online today, GSK reiterated its commitment to running its business responsibly and to making the company more responsive, more flexible and more open to the expectations of society.

19 Mar 2010

Cervical cancer vaccine may protect females from post-surgical recurrence

A vaccine designed to prevent cervical cancer also may protect females from post-surgical recurrence of the disease, according to researchers at the University of Alabama at Birmingham (UAB).

17 Mar 2010

Case management funds breast cancer screening and diagnostic services for low-income women

Case management appears to be associated with more appropriate follow-up and shorter time to diagnostic resolution among low-income women who receive an abnormal result on a mammogram, according to a report in the March 22 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

17 Mar 2010

Delphi Screener devices help detect HPV in women

More cases of human papillomavirus (HPV) infection - the major cause of cervical cancer - could be detected if home-testing kits were given to women who cannot attend conventional cervical screening, a Dutch study has found.

17 Mar 2010

Gardasil vaccine may protect women from post-surgical recurrence of cervical cancer

A vaccine designed to prevent cervical cancer also may protect females from post-surgical recurrence of the disease, according to researchers at the University of Alabama at Birmingham.

17 Mar 2010

Critical need for second NCI: Sylvester Comprehensive Cancer Center launches campaign

While Florida has the second highest cancer burden in the nation, the state has only one National Cancer Institute. Successfully applying for NCI designation must include a commitment for additional funding from the state. The Sylvester Comprehensive Cancer Center is launching “We Tackle Cancer” bringing attention to the critical need for a second NCI.

16 Mar 2010

Gardasil vaccine: Two complaints filed in Washington Federal Claims court

Anapol Schwartz attorneys Lawrence Cohan and Melissa Fry Hague recently filed two Gardasil vaccine complaints – one on behalf of a Kensington, Calif., family, whose 15-year old daughter died after suffering from severe adverse reactions, and another on behalf of a 19-year old Lapeer, Mich., woman, who has a chronic, autoimmune disorder. The cases, filed in The Court of Federal Claims in Washington, D.C., seek recovery under the National Vaccine Injury Compensation Program.

15 Mar 2010

In addition to anal and cervical cancer, HPV can also cause head and neck cancer

The Human Papillomavirus (HPV) is the causative agent responsible for most cases of cervical cancer, but is also associated with several other types of cancer.

12 Mar 2010

Collaborative center established to reduce obesity-related deaths in African-American and Latino communities

A $6 million grant from the National Heart, Lung and Blood Institute (NHLBI) has funded the creation of ORBIT: Obesity Related Behavioral Intervention Trials to focus on reducing obesity and obesity-related deaths in New York City's African-American and Latino communities.

11 Mar 2010

mtm laboratories launches CINtec PLUS screening system for cervical cancer

mtm laboratories, a privately held diagnostics company today announced the launch of CINtec® PLUS, the company’s next generation cervical cancer screening product with unmatched accuracy for the screening and management for cervical cancer. CINtec® PLUS will be launched with claims direct in Germany, Italy, Spain, France and the UK, and will also be available in other parts of the world via mtm’s nominated distributors.

8 Mar 2010

UTSA celebrates grand opening of NVI facility in the greater San Antonio region

The University of Texas at San Antonio celebrates the grand opening of its New Venture Incubator, a facility with laboratory, office and meeting spaces to support technology start-ups in the greater San Antonio region. The incubator, housed on UTSA’s Main Campus, will serve as a bridge between San Antonio entrepreneurs and the region’s research and development community.

8 Mar 2010

New guidance produced to help GPs identify symptoms of cervical cancer in young women

New guidance has been produced to help GPs identify symptoms of cervical cancer and facilitate early diagnosis of the disease in young women.

6 Mar 2010

Endothelial cells can produce copious amounts of adult stem cells: Study

In a leap toward making stem cell therapy widely available, researchers at the Ansary Stem Cell Institute at Weill Cornell Medical College have discovered that endothelial cells, the most basic building blocks of the vascular system, produce growth factors that can grow copious amounts of adult stem cells and their progeny over the course of weeks.

5 Mar 2010

Advaxis' Listeria based fusion protein granted U.S. patent

The US Patent and Trademark Office (USPTO) has issued Advaxis, Inc.,, the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, patent #7662396 titled “Compositions and Methods for Enhancing the Immunogenicity of Antigens” for the use of fusion proteins that have been found to be effective in numerous models for the treatment of cancer in the presence of immune tolerance.

5 Mar 2010

Boosting immune response to vaccinations: Role of aluminium adjuvants

An imminent publication in Trends in Immunology by a leading researcher in the bioinorganic chemistry of aluminium, Dr Christopher Exley, Reader in Bioinorganic Chemistry at The Birchall Centre, Keele University in Staffordshire, has now gone some way to giving the fullest possible explanation of how aluminium adjuvants work in boosting the immune response to vaccination.

4 Mar 2010

Inovio Biomedical introduces new CELLECTRA-SP series of hand-held, cordless electroporation devices

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, has unveiled its new CELLECTRA®-SP series of hand-held, cordless electroporation devices at the DNA Vaccines 2010 conference being held in New Orleans, LA.

3 Mar 2010

Cervical Cancer News and Research

Further Reading

PBCC supports passage of health care legislation

HPV test could help predict risk of cervical cancer, but more research needed

Cancer Research UK's special Race for Life event takes place in Essex

Global breast cancer organization recognizes Northeast Ohio Affiliate of Susan G. Komen for the Cure

GSK's 2009 Corporate Responsibility Report published online

Cervical cancer vaccine may protect females from post-surgical recurrence

Case management funds breast cancer screening and diagnostic services for low-income women

Delphi Screener devices help detect HPV in women

Gardasil vaccine may protect women from post-surgical recurrence of cervical cancer

Critical need for second NCI: Sylvester Comprehensive Cancer Center launches campaign

Gardasil vaccine: Two complaints filed in Washington Federal Claims court

In addition to anal and cervical cancer, HPV can also cause head and neck cancer

Collaborative center established to reduce obesity-related deaths in African-American and Latino communities

mtm laboratories launches CINtec PLUS screening system for cervical cancer

UTSA celebrates grand opening of NVI facility in the greater San Antonio region

New guidance produced to help GPs identify symptoms of cervical cancer in young women

Endothelial cells can produce copious amounts of adult stem cells: Study

Advaxis' Listeria based fusion protein granted U.S. patent

Boosting immune response to vaccinations: Role of aluminium adjuvants

Inovio Biomedical introduces new CELLECTRA-SP series of hand-held, cordless electroporation devices

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News